All News #Library
Biotech
Inhibikase Starts Enrollment in Global Phase 3 IMPROVE-PAH Trial
07 Apr 2026 //
GLOBENEWSWIRE
Inhibikase Therapeutics Progresses IKT-001 To Global Phase 3
20 Nov 2025 //
GLOBENEWSWIRE
Inhibikase Appoints Pfizer, Gilead Alum as CCO for PAH Launch
19 Aug 2025 //
FIERCE PHARMA
Former Inhibikase CEO launches new biotech for Parkinson`s asset
12 May 2025 //
FIERCE BIOTECH

Market Place
Sourcing Support